Pasithea Therapeutics Statistics
Total Valuation
KTTA has a market cap or net worth of $3.38 million. The enterprise value is -$3.54 million.
Important Dates
The last earnings date was Monday, March 24, 2025, after market close.
| Earnings Date | Mar 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KTTA has 2.71 million shares outstanding. The number of shares has decreased by -10.64% in one year.
| Current Share Class | 1.27M |
| Shares Outstanding | 2.71M |
| Shares Change (YoY) | -10.64% |
| Shares Change (QoQ) | +20.14% |
| Owned by Insiders (%) | 4.11% |
| Owned by Institutions (%) | 2.53% |
| Float | 891,016 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.12 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.58
| Current Ratio | 6.58 |
| Quick Ratio | 6.18 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -72.83% and return on invested capital (ROIC) is -46.55%.
| Return on Equity (ROE) | -72.83% |
| Return on Assets (ROA) | -42.23% |
| Return on Invested Capital (ROIC) | -46.55% |
| Return on Capital Employed (ROCE) | -95.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.74M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.35% in the last 52 weeks. The beta is 0.75, so KTTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | -81.35% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 3.64 |
| Relative Strength Index (RSI) | 45.74 |
| Average Volume (20 Days) | 76,514 |
Short Selling Information
The latest short interest is 26,658, so 0.99% of the outstanding shares have been sold short.
| Short Interest | 26,658 |
| Short Previous Month | 3,631 |
| Short % of Shares Out | 0.99% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.25M |
| Pretax Income | -16.28M |
| Net Income | -13.90M |
| EBITDA | -13.60M |
| EBIT | -14.25M |
| Earnings Per Share (EPS) | -$12.69 |
Full Income StatementBalance Sheet
The company has $6.92 million in cash and n/a in debt, giving a net cash position of $6.92 million or $2.56 per share.
| Cash & Cash Equivalents | 6.92M |
| Total Debt | n/a |
| Net Cash | 6.92M |
| Net Cash Per Share | $2.56 |
| Equity (Book Value) | 14.78M |
| Book Value Per Share | 10.60 |
| Working Capital | 6.25M |
Full Balance SheetCash Flow
| Operating Cash Flow | -13.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | -13.92M |
| FCF Per Share | -$5.15 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |